Nuran Katgi
Dr. Suat Seren Chest Diseases And Chest Surgery Training And Research Hospital, Izmir
Yenisehir, Turkey
Yenisehir, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein Overexpressing, Nonsquamous, EGFR Wild-type Advanced NSCLC: Updated Analysis of the LUMINOSITY Trial.
Journal: JTO clinical and research reports
Published: October 21, 2025
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR-Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 06, 2024
Comparison of Alectinib/Crizotinib Data in First-Line Therapy in Patients with Anaplastic LymphomakinasePositive Nonsmall Cell Lung Carcinoma with Poor Prognostic Features for Alectinib.
Journal: Thoracic research and practice
Published: July 24, 2023
Efficiency and Reliability of Bronchoscopic Lung Volume Reduction Coil Application in Patients with Severe Emphysema.
Journal: Sisli Etfal Hastanesi tip bulteni
Published: February 08, 2023
IMPORTANCE of PRETREATMENT 18F-FDG PET/CT TEXTURE ANALYSIS in PREDICTING EGFR and ALK MUTATION in PATIENTS with NON-SMALL CELL LUNG CANCER.
Journal: Nuklearmedizin. Nuclear medicine
Published: August 17, 2022
The Prognostic Value of 18F-FDG PET/CT Metabolic Parameters in Predicting Treatment Response Before EGFR TKI Treatment in Patients with Advanced Lung Adenocarcinoma.
Journal: Molecular imaging and radionuclide therapy
Published: June 30, 2022
PDL-1 Expression and Survival in Metastatic Non-small Cell Lung Cancer Patients Who Received Chemotherapy as First-Line Treatment.
Journal: Turkish thoracic journal
Published: February 03, 2022
Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study.
Journal: Journal of cancer research and clinical oncology
Published: November 30, 2021
Complication and cost analysis of transbronchial lung cryobiopsy and awake video-assisted thoracic surgery in diagnosis of interstitial lung disease.
Journal: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Published: September 15, 2021
Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA).
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: April 20, 2021
Diagnostic efficacy of EBUS-TBNA in benign diseases in a population with a high prevalence of tuberculosis.
Journal: Diagnostic cytopathology
Published: February 10, 2020
Diagnostic approach in parenchymal lung diseases: transbronchial lung biopsy or cryobiopsy?
Journal: Turkish journal of medical sciences
Published: October 15, 2019
Last Updated: 09/26/2026